Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Validation of a Genomic Classifier that Predicts Metastatic Disease Progression in Men with High Risk Pathological Features Post-Prostatectomy

Go back to Resources

Validation of a Genomic Classifier that Predicts Metastatic Disease Progression in Men with High Risk Pathological Features Post-Prostatectomy

Authors:

Secondary:

Location:

URL:

Go back to Resources

Treatments for Hypersensitive Noncarious Cervical Lesions: A Practitioners Engaged in Applied Research and Learning (PEARL) Network Randomized Clinical Effectiveness Study

Go back to Resources

Treatments for Hypersensitive Noncarious Cervical Lesions: A Practitioners Engaged in Applied Research and Learning (PEARL) Network Randomized Clinical Effectiveness Study

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Treatment of Geographic Atrophy with Subconjunctival Sirolimus: Results of a Phase I/II Clinical Trial

Go back to Resources

Treatment of Geographic Atrophy with Subconjunctival Sirolimus: Results of a Phase I/II Clinical Trial

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Therapeutic Vaccination Expands and Improves the Function of the HIV-Specific Memory T-Cell Repertoire

Go back to Resources

Therapeutic Vaccination Expands and Improves the Function of the HIV-Specific Memory T-Cell Repertoire

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The Natural History of Milk Allergy in an Observational Cohort

Go back to Resources

The Natural History of Milk Allergy in an Observational Cohort

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Ten-year Incidence Rates of Age-Related Cataract in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 33

Go back to Resources

Ten-year Incidence Rates of Age-Related Cataract in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 33

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Substance-Use Screening and Interventions in Dental Practices: Survey of Practice-Based Research Network Dentists Regarding Current Practices, Policies and Barriers

Go back to Resources

Substance-Use Screening and Interventions in Dental Practices: Survey of Practice-Based Research Network Dentists Regarding Current Practices, Policies and Barriers

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females

Go back to Resources

Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial

Go back to Resources

Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Restoration Variables and Postoperative Hypersensitivity in Class I Restorations: PEARL Network Findings. Part 2

Go back to Resources

Restoration Variables and Postoperative Hypersensitivity in Class I Restorations: PEARL Network Findings. Part 2

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 206
  • Page 207
  • Page 208
  • Page 209
  • Current page 210
  • Page 211
  • Page 212
  • Page 213
  • Page 214
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification